Transfer-pricing treatment of ITeS margins excludes pass-through tax recoveries and separate delayed-receivables interest after working-capital adjust...
Capacity-utilisation adjustments under TNMM can neutralise substantiated COVID-related idle costs where underutilisation materially affects profitabil...
TNMM functional comparability requires excluding rice manufacturers from a pure Basmati rice trader's benchmark and recognising operating export recei...
Working-capital adjustment subsumes delayed-receivable effects in TNMM benchmarking of captive software-development services, avoiding separate notion...
Transfer-pricing comparability requires exclusion of financially illogical super-profit comparables and correction of unsupported annual-report and ma...
Charitable character assessment preserves Section 80G approval despite inclusive spiritual teachings and incidental religious expenditure within the s...
Penalty proceedings for cash-loan acceptance require assessment proceedings and recorded Assessing Officer satisfaction; absent these, the proceedings...
Page of 4828
Press 'Enter' after typing page number.
161 to 180 of 96556 Results
❮
❯
❯❯
0 / 200
Expand Note
Add to Folder
No Folders have been created
+
Are you sure you want to delete "My most important" ?
The HC directed the first and second respondents to permit clearance of the petitioner's imported ayurvedic drug consignment subject to compliance with statutory standards under the Drugs & Cosmetics Act and Rules. Recognizing the applicability of the statute to ayurvedic drugs and the absence of specific import rules, the court mandated testing of the product by a CDSCO-accredited laboratory under the supervision of the fifth respondent, the licensing authority for ayurvedic drugs. The petitioner must bear all testing costs. Upon receipt of a satisfactory laboratory report certifying conformity with Indian manufacturing standards, the fifth respondent shall issue a certificate to the first and second respondents, who shall then allow release of the goods covered by the relevant bill of entry. The petition was accordingly disposed of, ensuring regulatory compliance while facilitating import clearance.
The HC directed the first and second respondents to permit clearance of the petitioner's imported ayurvedic drug consignment subject to compliance with statutory standards under the Drugs & Cosmetics Act and Rules. Recognizing the applicability of the statute to ayurvedic drugs and the absence of specific import rules, the court mandated testing of the product by a CDSCO-accredited laboratory under the supervision of the fifth respondent, the licensing authority for ayurvedic drugs. The petitioner must bear all testing costs. Upon receipt of a satisfactory laboratory report certifying conformity with Indian manufacturing standards, the fifth respondent shall issue a certificate to the first and second respondents, who shall then allow release of the goods covered by the relevant bill of entry. The petition was accordingly disposed of, ensuring regulatory compliance while facilitating import clearance.
Note: It is a system-generated summary and is for quick reference only.